The histological characteristics of clinically normal mucosa adjacent to oral cancer

Journal of Cancer Research and Therapeutics

Volumn 9, Issue 2, 2013, Pages 240-244

  Cankovic, Milos ^a   Ilic, Miroslav ^b   Vuckovic, Nada ^b   Bokor Bratic, Marija ^a  

^a UNIVERSITY OF NOVI SAD   (Serbia)

^b Clinical Centre of Vojvodina   (Serbia)

Author keywords

Dysplasia; field change; histopathology; oral cancer; squamous cell carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; MALE; MICROSCOPY; MOUTH MUCOSA; MOUTH SQUAMOUS CELL CARCINOMA; ORAL BIOPSY; PROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; MALE; MIDDLE AGED; MOUTH MUCOSA; MOUTH NEOPLASMS; PRECANCEROUS CONDITIONS; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84880121124     PISSN: 09731482     EISSN: 19984138     Source Type: Journal    
DOI: 10.4103/0973-1482.113365     Document Type: Article

References (26)

1. Dakubo GD, Jakupciak JP, Birch-Machin MA, Parr RL. Clinical implications and utility of field cancerization. Cancer Cell Int 2007;7:2
2. Hittelmann WN. Genetic instability in epithelial tissues at risk for cancer. Ann NY Acad Sci 2001;952:1-12
3. Tabor MP, Brakenhoff RH, van Houten VM, Kummer JA, Snel MH, Snijders PJ, et al. Persistence of genetically altered fields in head and neck cancer patients: Biological and clinical implications. Clin Cancer Res 2001;7:1523-32
4. Van Oijen MG, Slootweg PJ. Oral field cancerisation: Carcinogeninducedindependet events or micrometastasis deposits? Cancer Epidemiol Biomarkers Prev 2000;9:249-56
5. Mashberg A. Diagnosis of early oral and oropharyngeal squamous carcinoma: Obstacles and their amelioration. Oral Oncol 2000;36:253-5
6. Sutton DN, Brown JS, Rogers SN, Vaughan ED, Woolgar JA. The prognostic implications of the surgical margin in oral squamous cell carcinoma. Int J Oral Maxillofac Surg 2003;32:30-4
7. Cianfrigkia F, Di Gregorio DA, Manieri A. Multiple primary tumors in patients with oral squamous cell carcinoma. Oral Oncol 1999;35:157-63
8. De Vries N, van dr Waal I, Snow GB. Multiple primary tumors in oral cancer. Int J Oral Maxillofac Surg 1986;15:85-7
9. Priya SR, D'Cruz AK, Pai PS. Cut margins and disease control in oral cancers. J Cancer Res Ther 2012;8:74-9
10. Thomson PJ. Field change and oral cancer: New evidence for widespread carcinogenesis? Int J Oral Maxillofac Surg 2002;31:262-6
11. Incze J, Vaughan CW, Lui P, Strong MS, Kulapaditharom B. Premalignant changes in normal appearing epithelium in patients with squamouse cell carcinom of the upper aerodigestiv tract. Am J Surg 1982;144:401-5
12. Vieira FL, Vieira BJ, Guimaraes MA, Aarestrup FM. Cellular profile of the peritumoral inflammatory infiltrate in squamouse cell carcinoma of the oral mucose: Correlation with the expression of Ki67 and histologic grading. BMC Oral Health 2008;8:25
13. Bloching M, Hofmann A, Lautenschlager CH, Berghaus A, Grummt T. Exfoliative cytology of normal buccal mucosa to predict the relative risk of cancer in the upper aerodigestive tract using the MN-assay. Oral Oncol 2000;36:550-5
14. Tabor MP, Braakhuis BJ, Van Der Wal JE, van Diest PJ, Leemans CR, Brakenhoff RH, et al. Comparative molecular and histological grading of epithelial dyspalsia of the oral cavity and the oropharynx. J Pathol 2003;199:354-60
15. Tabor MP, Brakenhoff RH, Ruijter-Schippers HJ, Kummer JA, Leemans CR, Braakhuis BJ. Genetically altered fields as origin of locally reccurent head and neck cancer: A retrospective study. Clin Cancer Res 2004;10:3607-13
16. van Houten VM, Leemans CR, Kummer JA, Dijkstra J, Kuik DJ, van der Brekel MW, et al. Molecular diagnosis of surgical margins and local recurrence in head and neck cancer patients: A prospective study. Clin Cancer Res 2004;10:3614-20
17. Huang X, Pateromichelakis S, Hills A, Sherriff M, Lyons A, Langdon J, et al. p53 mutations in deep tissues are more strongly associated with recurrence than mutation-positive mucosal margins. Clin Cancer Res 2007;13:6099-106
18. vanHouten VM, Tabor MP, van den Brekel MW, Kummer JA, Denkers F, Dijkstra J, et al. Mutated p53 as a molecular marker for the diagnosis of haed and neck cancer. J Pathol 2002;198:476-86
19. Bongers V, Snow GB, van der Waal I, Braakhuis BJ. Value of p53 expression in oral cancer and adjacent normal mucosa in relation to the occurrence of multiple primary carcinomas. Eur J Cancer B Oral Oncol 1995;31B:392-5
20. Bilde A, von Buchwald C, Dabelsteen E, Therkildsen MH, Dabelsteen S. Molecular markers in the surgical margin of oral carcinomas. J Oral Pathol Med 2009;38:72-8
21. Thode C, Bilde A, von Buchwald C, Dabelsteen E. TP53 mutations in clinically normal mucosa adjacent to oral carcinomas. J Oral Pathol Med 2010;39:662-6
22. Tabor MP, Brakenhoff RH, Ruijter-Schippers HJ, van der Wal JE, Snow GB, Leemans CR, et al. Multiple head and neck tumors frequently originate from a single preneoplastic lesion. Am J Pathol 2002;161:1051-60
23. El-Gazzar R, Macluskey M, Ogden GR. Evidence for a field change effect based on angiogenesis in the oral mucosa? A brief report. Oral Oncol 2005;41:25-30
24. Poh CF, Zhang L, Anderson DW, Durham JS, Williams PM, Priddy RW, et al. Fluorescence visualization detection of field alterations in tumor margins of oral cancer patients. Clin Cancer Res 2006;12:6716-22
25. Montebugnoli L, Gissi DB, Badiali G, Marchetti C, Cervellati F, Farnedi A, et al. Ki-67 from clinically and histologically normal distant mucosa as prognostic marker in early-stage (T1-T2N0) oral squamous cell carcinoma: Aprospective study. J Oral Maxillofac Surg 2011;69:2579-84
26. Gonzales-Moles MA, Bravo M, Ruiz-Avila I, Acebal F, Gil-Montoya JA, Brener S, et al. Ki-67 expression in non-tumour epithelium adjacent to oral cancer as risk marker for multiple oral tumors. Oral Dis 2010;16:68-75.